formoterol
Despite these effects, the short-acting beta-agonist drugs        albuterol and terbutaline and the long-acting beta-agonist drugs salmeterol and       formoterol have, in general, not been associated with a significant worsening of        asthma control or an increased frequency of severe attacks.
Despite these effects, the short-acting beta-agonist drugs        albuterol and terbutaline and the long-acting beta-agonist drugs salmeterol and        @SUBJECT$  have, in general, not been associated with a significant worsening of         @OBJECT$   @PREDICAT$  or an increased frequency of severe attacks.